[1]
|
Tysnes, O.B. and Storstein, A. (2017) Epidemiology of Parkinson’s Disease. Journal of Neural Transmission (Vienna), 124, 901-905. https://doi.org/10.1007/s00702-017-1686-y
|
[2]
|
Reich, S.G. and Savitt, J.M. (2019) Parkinson’s Disease. Medical Clinics of North America, 103, 337-350.
https://doi.org/10.1016/j.mcna.2018.10.014
|
[3]
|
Polo-Morales, A., et al. (2020) Association between Somatization and Nonmotor Symptoms Severity in People with Parkinson Disease. Journal of Geriatric Psychiatry and Neurology, 891988720901787.
|
[4]
|
Dickson, D.W. (2018) Neuropathology of Parkinson Disease. Parkinsonism & Related Disorders, 46, S30-S33.
https://doi.org/10.1016/j.parkreldis.2017.07.033
|
[5]
|
Delamarre, A. and Meissner, W.G. (2017) Epidemiology, Environmental Risk Factors and Genetics of Parkinson’s Disease. La Presse Médicale, 46, 175-181. https://doi.org/10.1016/j.lpm.2017.01.001
|
[6]
|
Polymeropoulos, M.H., Lavedan, C., Leroy, E., et al. (1997) Muta-tion in the Alpha-Synuclein Gene Identified in Families with Parkinson’s Disease. Science, 276, 2045-2047. https://doi.org/10.1126/science.276.5321.2045
|
[7]
|
Deng, H., Wang, P. and Jankovic, J. (2018) The Genetics of Parkinson Disease. Ageing Research Reviews, 42, 72-85.
https://doi.org/10.1016/j.arr.2017.12.007
|
[8]
|
Kim, C.Y. and Alcalay, R.N. (2017) Genetic Forms of Parkinson’s Disease. Seminars in Neurology, 37, 135-146.
https://doi.org/10.1055/s-0037-1601567
|
[9]
|
Koros, C., Simitsi, A. and Stefanis, L. (2017) Genetics of Parkinson’s Disease: Genotype-Phenotype Correlations. International Review of Neurobiology, 132, 197-231. https://doi.org/10.1016/bs.irn.2017.01.009
|
[10]
|
Seo, S.H., et al. (2020) Replication-Based Rearrangements Are a Common Mechanism for SNCA Duplication in Parkinson’s Disease. Movement Disorders: Official Journal of the Movement Disorder Society.
|
[11]
|
Ferese, R., Modugno, N., Campopiano, R., et al. (2015) Four Copies of SNCA Re-sponsible for Autosomal Dominant Parkinson’s Disease in Two Italian Siblings. Parkinson’s Disease, 2015, Article ID: 546462.
https://doi.org/10.1155/2015/546462
|
[12]
|
Xiong, W.X., Sun, Y.M., Guan, R.Y., et al. (2016) The Heterozygous A53T Mutation in the Alpha-Synuclein Gene in a Chinese Han Patient with Parkinson Disease: Case Report and Lit-erature Review. Journal of Neurology, 263, 1984-1992. https://doi.org/10.1007/s00415-016-8213-1
|
[13]
|
Yu, W.J., Cheng, L., Li, N.N., et al. (2015) Interaction between SNCA, LRRK2 and GAK Increases Susceptibility to Parkinson’s Disease in a Chinese Population. eNeurologicalSci, 1, 3-6. https://doi.org/10.1016/j.ensci.2015.08.001
|
[14]
|
Li, N.N., Mao, X.Y., Chang, X.L., et al. (2013) SNCA rs356219 Variant Increases Risk of Sporadic Parkinson’s Disease in Ethnic Chinese. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 162, 452-456.
https://doi.org/10.1002/ajmg.b.32143
|
[15]
|
Cheng, L., Wang, L., Li, N.N., et al. (2016) SNCA rs356182 Variant Increases Risk of Sporadic Parkinson’s Disease in Ethnic Chinese. Journal of the Neurological Sciences, 368, 231-234. https://doi.org/10.1016/j.jns.2016.07.032
|
[16]
|
Huang, Y., Wang, G., Rowe, D., et al. (2015) SNCA Gene, But Not MAPT, Influences Onset Age of Parkinson’s Disease in Chinese and Australians. BioMed Research International, 2015, Article ID: 135674.
https://doi.org/10.1155/2015/135674
|
[17]
|
Chen, W., Kang, W.Y., Chen, S., et al. (2015) Hyposmia Correlates with SNCA Variant and Non-Motor Symptoms in Chinese Patients with Parkinson’s Disease. Parkinsonism & Related Disorders, 21, 610-614.
https://doi.org/10.1016/j.parkreldis.2015.03.021
|
[18]
|
Zheng, J., Yang, X., Zhao, Q., et al. (2017) Association between Gene Polymorphism and Depression in Parkinson’s Disease: A Case-Control Study. Journal of the Neurolog-ical Sciences, 375, 231-234.
https://doi.org/10.1016/j.jns.2017.02.001
|
[19]
|
Ross, O.A., Soto-Ortolaza, A.I., Heckman, M.G., et al. (2011) As-sociation of LRRK2 Exonic Variants with Susceptibility to Parkinson’s Disease: A Case-Control Study. The Lancet Neurology, 10, 898-908.
https://doi.org/10.1016/S1474-4422(11)70175-2
|
[20]
|
Fu, X., Zheng, Y., Hong, H., et al. (2013) LRRK2 G2385R and LRRK2 R1628P Increase Risk of Parkinson’s Disease in a Han Chinese Population from Southern Mainland China. Parkinsonism & Related Disorders, 19, 397-398.
https://doi.org/10.1016/j.parkreldis.2012.08.007
|
[21]
|
Xie, C.L., Pan, J.L., Wang, W.W., et al. (2014) The Associ-ation between the LRRK2 G2385R Variant and the Risk of Parkinson’s Disease: A Meta-Analysis Based on 23 Case-Control Studies. Neurological Sciences, 35, 1495-1504.
https://doi.org/10.1007/s10072-014-1878-2
|
[22]
|
Zhang, J.R., Jin, H., Li, K., et al. (2018) Genetic Analysis of LRRK2 in Parkinson’s Disease in Han Chinese Population. Neurobiology of Aging, 72, 187 e5-187 e10. https://doi.org/10.1016/j.neurobiolaging.2018.06.036
|
[23]
|
Wang, C., Cai, Y., Gu, Z., et al. (2014) Clinical Profiles of Parkinson’s Disease Associated with Common Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Genetic Vari-ants in Chinese Individuals. Neurobiology of Aging, 35, 725e1-6.
https://doi.org/10.1016/j.neurobiolaging.2013.08.012
|
[24]
|
Gao, C., Pang, H., Luo, X.G., et al. (2013) LRRK2 G2385R Variant Carriers of Female Parkinson’s Disease Are More Susceptible to Motor Fluctuation. Journal of Neu-rology, 260, 2884-2889. https://doi.org/10.1007/s00415-013-7086-9
|
[25]
|
Fu, R., Cui, S.S., Du, J.J., et al. (2017) Fatigue Correlates with LRRK2 G2385R Variant in Chinese Parkinson’s Disease Patients. Parkinsonism & Related Disorders, 44, 101-105. https://doi.org/10.1016/j.parkreldis.2017.09.016
|
[26]
|
Li, D.W., Gu, Z., Wang, C., et al. (2015) Non-Motor Symptoms in Chinese Parkinson’s Disease Patients with and without LRRK2 G2385R and R1628P Variants. Journal of Neural Transmission (Vienna), 122, 661-667.
https://doi.org/10.1007/s00702-014-1281-4
|
[27]
|
Funayama, M., Ohe, K., Amo, T., et al. (2015) CHCHD2 Muta-tions in Autosomal Dominant Late-Onset Parkinson’s Disease: A Genome-Wide Linkage and Sequencing Study. The Lancet Neurology, 14, 274-282.
https://doi.org/10.1016/S1474-4422(14)70266-2
|
[28]
|
Li, N.N., Wang, L., Tan, E.K., et al. (2016) Genetic Analysis of CHCHD2 Gene in Chinese Parkinson’s Disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 171, 1148-1152.
https://doi.org/10.1002/ajmg.b.32498
|
[29]
|
Lu, Q., Deng, X., Song, Z., et al. (2016) Mutation Analysis of the CHCHD2 Gene in Chinese Han Patients with Parkinson’s Disease. Parkinsonism & Related Disorders, 29, 143-144. https://doi.org/10.1016/j.parkreldis.2016.04.012
|
[30]
|
Liu, Z., Guo, J., Li, K., et al. (2015) Mutation Analysis of CHCHD2 Gene in Chinese Familial Parkinson’s Disease. Neurobiology of Aging, 36, 3117e7-3117e8. https://doi.org/10.1016/j.neurobiolaging.2015.08.010
|
[31]
|
Yang, N., Zhao, Y., Liu, Z., et al. (2019) Systematically Analyzing Rare Variants of Autosomal-Dominant Genes for Sporadic Parkinson’s Disease in a Chinese Cohort. Neurobiology of Aging, 76, 215e1-215e7.
https://doi.org/10.1016/j.neurobiolaging.2018.11.012
|
[32]
|
Shi, C.H., Mao, C.Y., Zhang, S.Y., et al. (2016) CHCHD2 Gene Mutations in Familial and Sporadic Parkinson’s Disease. Neurobiology of Aging, 38, 217e9-217e13. https://doi.org/10.1016/j.neurobiolaging.2015.10.040
|
[33]
|
Li, K., Tang, B.S., Guo, J.F., et al. (2013) Analysis of EIF4G1 in Ethnic Chinese. BMC Neurology, 13, 38.
https://doi.org/10.1186/1471-2377-13-38
|
[34]
|
Guo, J.F., Sun, Q.Y., Lv, Z.Y., et al. (2012) VPS35 Gene Variants Are Not Associated with Parkinson’s Disease in the Mainland Chinese Population. Parkinsonism & Related Disorders, 18, 983-985.
https://doi.org/10.1016/j.parkreldis.2012.05.002
|
[35]
|
Cao, L., Zhang, T., Zheng, L., et al. (2010) The GIGYF2 Variants Are Not Associated with Parkinson’s Disease in the Mainland Chinese Population. Parkinsonism & Related Disorders, 16, 294-297.
https://doi.org/10.1016/j.parkreldis.2009.11.009
|
[36]
|
Van der Merwe, C., Jalali Sefid Dashti, Z., Christoffels, A., et al. (2015) Evidence for a Common Biological Pathway Linking Three Parkinson’s Disease-Causing Genes: Parkin, PINK1 and DJ-1. European Journal of Neuroscience, 41, 1113-1125. https://doi.org/10.1111/ejn.12872
|
[37]
|
Kalinderi, K., Bostantjopoulou, S. and Fidani, L. (2016) The Genetic Back-ground of Parkinson’s Disease: Current Progress and Future Prospects. Acta Neurologica Scandinavica, 134, 314-326. https://doi.org/10.1111/ane.12563
|
[38]
|
Guo, J.F., Dong, X.L., Xu, Q., et al. (2015) Exon Dosage Analysis of Parkin Gene in Chinese Sporadic Parkinson’s Disease. Neuroscience Letters, 604, 47-51. https://doi.org/10.1016/j.neulet.2015.07.046
|
[39]
|
Huang, T., Gao, C.Y., Wu, L., et al. (2019) Han Chinese Family with Early-Onset Parkinson’s Disease Carries Novel Compound Heterozygous Mutations in the PARK2 Gene. Brain and Behavior, 9, e01372.
https://doi.org/10.1002/brb3.1372
|
[40]
|
Li, H., Yusufujiang, A., Naser, S., et al. (2014) Mutation Analysis of PARK2 in a Uyghur Family with Early-Onset Parkinson’s Disease in Xinjiang, China. Journal of the Neurological Sciences, 342, 21-24.
https://doi.org/10.1016/j.jns.2014.03.044
|
[41]
|
Chen, M., Cen, Z., Chen, Y., et al. (2018) Genetic Study of a Par-kinson’s Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene. Chinese Journal of Medical Genetics, 35, 815-818.
|
[42]
|
Taylor, J.M., Wu, R.M., Lin, C.H., et al. (2009) Lack of Evidence for Association of a Parkin Promoter Polymorphism with Early-Onset Parkinson’s Disease in a Chinese Population. Parkinsonism & Related Disorders, 15, 149-152.
https://doi.org/10.1016/j.parkreldis.2008.02.010
|
[43]
|
Chan, D.K., Mok, V., Ng, P.W., et al. (2008) PARK2 Mu-tations and Clinical Features in a Chinese Population with Early-Onset Parkinson’s Disease. Journal of Neural Trans-mission (Vienna), 115, 715-719.
https://doi.org/10.1007/s00702-007-0011-6
|
[44]
|
Wang, Y., Wu, J.J., Liu, F.T., et al. (2017) Olfaction in Parkin Carriers in Chinese Patients with Parkinson Disease. Brain and Behavior, 7, e00680. https://doi.org/10.1002/brb3.680
|
[45]
|
Hernandez, D.G., Reed, X. and Singleton, A.B. (2016) Genetics in Parkinson Disease: Mendelian versus Non-Mendelian Inheritance. Journal of Neurochemistry, 139, 59-74. https://doi.org/10.1111/jnc.13593
|
[46]
|
Arena, G. and Valente, E.M. (2017) PINK1 in the Limelight: Multiple Functions of an Eclectic Protein in Human Health and Disease. The Journal of Pathology, 241, 251-263. https://doi.org/10.1002/path.4815
|
[47]
|
Bonifati, V., Rohe, C.F., Breedveld, G.J., et al. (2005) Early-Onset Par-kinsonism Associated with PINK1 Mutations: Frequency, Genotypes, and Phenotypes. Neurology, 65, 87-95. https://doi.org/10.1212/01.wnl.0000167546.39375.82
|
[48]
|
Trinh, J. and Farrer, M. (2013) Advances in the Ge-netics of Parkinson Disease. Nature Reviews Neurology, 9, 445-454.
https://doi.org/10.1038/nrneurol.2013.132
|
[49]
|
Li, N., et al. (2020) Whole-Exome Sequencing in Early-Onset Parkinson’s Disease among Ethnic Chinese. Neurobiology of Aging.
|
[50]
|
Zhang, B.R., Hu, Z.X., Yin, X.Z., et al. (2010) Mutation Analysis of Parkin and PINK1 Genes in Early-Onset Parkinson’s Disease in China. Neuroscience Letters, 477, 19-22. https://doi.org/10.1016/j.neulet.2010.04.026
|
[51]
|
Wang, F., Chen, B., Feng, X.L., et al. (2007) PINK1 IVS5-5 G > A Polymorphism May Contribute to the Risk of Late Onset Parkinson Disease in Chinese. Chinese Journal of Medical Genetics, 24, 305-309.
|
[52]
|
Wang, F., Feng, X., Ma, J., et al. (2006) A Common A340T Variant in PINK1 Gene Associated with Late-Onset Parkinson’s Disease in Chinese. Neuroscience Letters, 410, 121-125. https://doi.org/10.1016/j.neulet.2006.09.080
|
[53]
|
张玉虎. 常染色体隐性遗传早发性帕金森综合征6型PINK1基因的突变分析[J]. 中华医学杂志, 2005, 22(85): 1538-1541.
|
[54]
|
van der Vlag, M., et al. (2020) The Contribution of Parkin, PINK1 and DJ-1 Genes to Selective Neuronal Degeneration in Parkinson’s Disease. The European Journal of Neuroscience.
|
[55]
|
Bonifati, V., Rizzu, P., Squitieri, F., et al. (2003) DJ-1(PARK7), a Novel Gene for Autosomal Recessive, Early Onset Parkinsonism. Neurological Sciences, 24, 159-160. https://doi.org/10.1007/s10072-003-0108-0
|
[56]
|
Huo, Z., Luo, X., Zhan, X., et al. (2017) Genetic Analysis of Indel Markers in Three Loci Associated with Parkinson’s Disease. PLoS ONE, 12, e0184269. https://doi.org/10.1371/journal.pone.0184269
|
[57]
|
Chen, W., Peng, R., Li, T., et al. (2008) Association of the DJ-1 Gene Polymorphism with Sporadic Parkinson’s Disease in Sichuan Province of China. Chinese Journal of Medical Ge-netics, 25, 566-569.
|
[58]
|
Pan, L.S., Wang, Z., Ding, D., et al. (2016) Lack of Association between the ATP13A2 A746T Variant and Parkinson’s Disease Susceptibility in Han Chinese: A Meta-Analysis. International Journal of Neuroscience, 126, 593-599.
https://doi.org/10.3109/00207454.2015.1035377
|
[59]
|
Li, G., Zhang, Z., Xia, H., et al. (2014) Analysis of Thr12Met and Ala1144Thr Mutations of the ATP13A2 Gene in Parkinson’s Disease Patients in Xinjiang Uygur and Han Ethnic Groups. Medical Science Monitor, 20, 2177-2182.
https://doi.org/10.12659/MSM.892821
|
[60]
|
Shi, C., Li, F., Yang, J., et al. (2016) DNAJC6 Mutations Are Not Common Causes of Early Onset Parkinson’s Disease in Chinese Han Population. Neuroscience Letters, 634, 60-62. https://doi.org/10.1016/j.neulet.2016.09.044
|
[61]
|
Wang, L., Cheng, L., Li, N.N., et al. (2016) Association of Four New Candidate Genetic Variants with Parkinson’s Disease in a Han Chinese Population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 171, 342-347. https://doi.org/10.1002/ajmg.b.32410
|
[62]
|
Mullin, S., Hughes, D., Mehta, A., et al. (2019) Neurological Effects of Glucocerebrosidase Gene Mutations. European Journal of Neurology, 26, 388-e29. https://doi.org/10.1111/ene.13837
|
[63]
|
Sidransky, E., Nalls, M.A., Aasly, J.O., et al. (2009) Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson’s Disease. The New England Journal of Medicine, 361, 1651-1661. https://doi.org/10.1056/NEJMoa0901281
|
[64]
|
Migdalska-Richards, A. and Schapira, A.H. (2016) The Relationship between Glucocerebrosidase Mutations and Parkinson Disease. Journal of Neurochem-istry, 139, 77-90. https://doi.org/10.1111/jnc.13385
|
[65]
|
Zhang, Y., et al. (2018) GBAIntegrated Genetic Analysis of Racial Differences of Common Variants in Parkinson’s Disease: A Meta-Analysis. Frontiers in Molecular Neu-roscience, 11, 43. https://doi.org/10.3389/fnmol.2018.00043
|
[66]
|
Guo, J.F., Li, K., Yu, R.L., et al. (2015) Poly-genic Determinants of Parkinson’s Disease in a Chinese Population. Neurobiology of Aging, 36, 1765e1-1765e6. https://doi.org/10.1016/j.neurobiolaging.2014.12.030
|
[67]
|
Shi, C., Zheng, Z., Wang, Q., et al. (2016) Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn-Yahr Stage. PLoS ONE, 11, e0155758. https://doi.org/10.1371/journal.pone.0155758
|
[68]
|
Yu, Z., Wang, T., Xu, J., et al. (2015) Mutations in the Glucocerebrosidase Gene Are Responsible for Chinese Patients with Parkinson’s Disease. Journal of Human Genetics, 60, 85-90. https://doi.org/10.1038/jhg.2014.110
|
[69]
|
Fan, K., Tang, B.S., Wang, Y.Q., et al. (2016) The GBA, DYRK1A and MS4A6A Polymorphisms Influence the Age at Onset of Chinese Parkinson Patients. Neuroscience Let-ters, 621, 133-136.
https://doi.org/10.1016/j.neulet.2016.04.014
|
[70]
|
Wu, Y.R., Chen, C.M., Chao, C.Y., et al. (2007) Glucocerebrosidase Gene Mutation Is a Risk Factor for Early Onset of Parkinson Disease among Taiwanese. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 977-979.
https://doi.org/10.1136/jnnp.2006.105940
|
[71]
|
Hu, F.Y., Xi, J., Guo, J., et al. (2010) Association of the Glucocerebrosidase N370S Allele with Parkinson’s Disease in Two Separate Chinese Han Populations of Mainland China. European Journal of Neurology, 17, 1476-1478.
https://doi.org/10.1111/j.1468-1331.2010.03097.x
|
[72]
|
Sidransky, E., et al. (2009) Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson’s Disease. The New England Journal of Medicine, 361, 1651-1661. https://doi.org/10.1056/NEJMoa0901281
|
[73]
|
Dan, X., Wang, C., Zhang, J., et al. (2016) Association between Common Genetic Risk Variants and Depression in Parkinson’s Disease: A dPD Study in Chinese. Parkinsonism & Re-lated Disorders, 33, 122-126.
https://doi.org/10.1016/j.parkreldis.2016.09.029
|
[74]
|
Pascale, E., Di Battista, M.E., Rubino, A., et al. (2016) Ge-netic Architecture of MAPT Gene Region in Parkinson Disease Subtypes. Frontiers in Cellular Neuroscience, 10, 96. https://doi.org/10.3389/fncel.2016.00096
|
[75]
|
Fagan, E.S. and Pihlstrom, L. (2017) Genetic Risk Factors for Cog-nitive Decline in Parkinson’s Disease: A Review of the Literature. European Journal of Neurology, 24, 561-e20. https://doi.org/10.1111/ene.13258
|
[76]
|
Kalinderi, K., Fidani, L. and Bostantjopoulou, S. (2009) From 1997 to 2007: A Decade Journey through the H1 Haplotype on 17q21 Chromosome. Parkinsonism & Related Disorders, 15, 2-5.
https://doi.org/10.1016/j.parkreldis.2008.03.001
|
[77]
|
Yu, L., Huang, J., Zhai, D., et al. (2014) MAPT rs242562 and GSK3B rs334558 Are Associated with Parkinson’s Disease in Central China. BMC Neuroscience, 15, 54. https://doi.org/10.1186/1471-2202-15-54
|
[78]
|
Dan, X., Wang, C., Ma, J., et al. (2014) MAPT IVS1 + 124 C > G Modifies Risk of LRRK2 G2385R for Parkinson’s Disease in Chinese Individuals. Neurobiology of Aging, 35, 1780e7-1780e10.
https://doi.org/10.1016/j.neurobiolaging.2014.01.025
|
[79]
|
Wang, G., Huang, Y., Chen, W., et al. (2016) Variants in the SNCA Gene Associate with Motor Progression While Variants in the MAPT Gene Associate with the Severity of Parkinson’s Disease. Parkinsonism & Related Disorders, 24, 89-94. https://doi.org/10.1016/j.parkreldis.2015.12.018
|